The California Division of Workers’ Compensation Pharmacy and Therapeutics Committee is meeting virtually on Oct. 16.
The 2015 bill that directed the DWC to create a prescription drug formulary also created the P&T Committee to review available evidence of the relative safety, efficacy and effectiveness of drugs or a class of drugs in updating to the formulary.
Committee members are slated to discuss issues relating to the Medical Treatment Utilization Schedule drug list, which identifies medications that can be prescribed without utilization review. Members will discuss incorporat...
Comments